Loading clinical trials...
Loading clinical trials...
Open Label Extension Study for 43USSA1705 (A Randomized, Evaluator-blinded, Multi-center Study to Evaluate the Safety and Effectiveness of Sculptra Aesthetic for Correction of Nasolabial Folds)
Conditions
Interventions
Sculptra Aesthetic, Lidocaine HCL
Locations
4
United States
Galderma Study Site
Scottsdale, Arizona, United States
Galderma Study Site
Bradenton, Florida, United States
Galderma Study Site
Austin, Texas, United States
Galderma Study Site
Spring, Texas, United States
Start Date
December 3, 2019
Primary Completion Date
January 29, 2021
Completion Date
January 29, 2021
Last Updated
March 12, 2025
NCT06657365
NCT07109635
NCT06216418
NCT03650387
NCT02672644
NCT03753152
Lead Sponsor
Galderma R&D
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions